|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/00 |
| (11) | Number of the document | 2364732 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11164996.8 |
| Date of filing the European patent application | 2007-03-20 | |
| (97) | Date of publication of the European application | 2011-09-14 |
| (45) | Date of publication and mention of the grant of the patent | 2016-07-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 06111523 | 2006-03-22 | EP | |
| 06021815 | 2006-10-18 | EP |
| (72) |
Friess, Thomas, DE
Hasmann, Max, DE
Scheuer, Werner, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacher Strasse 124, 4070 Basel,
CH
|
| (54) | Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2 |
| Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2 |